A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Therapeutic Effect of Magnesium-L-Threonate Supplementation for Persistent Pain After Breast Cancer Surgery
Yuncheng Ni,1 Fang Deng,1 Shanzi Yu,1 Jianping Zhang,1 Xiaoxue Zhang,1 Dong Huang,1,2 Haocheng Zhou1,2 1Department of Pain, the Third Xiangya Hospital and Institute of Pain Medicine, Central South University, Changsha, People’s Republic of China; 2Hunan Key Laboratory of Brain Homeostasis, Central S...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2023-07-01
|
| Series: | Breast Cancer: Targets and Therapy |
| Subjects: | |
| Online Access: | https://www.dovepress.com/a-randomized-double-blind-placebo-controlled-trial-to-evaluate-the-the-peer-reviewed-fulltext-article-BCTT |
| _version_ | 1797772677641928704 |
|---|---|
| author | Ni Y Deng F Yu S Zhang J Zhang X Huang D Zhou H |
| author_facet | Ni Y Deng F Yu S Zhang J Zhang X Huang D Zhou H |
| author_sort | Ni Y |
| collection | DOAJ |
| description | Yuncheng Ni,1 Fang Deng,1 Shanzi Yu,1 Jianping Zhang,1 Xiaoxue Zhang,1 Dong Huang,1,2 Haocheng Zhou1,2 1Department of Pain, the Third Xiangya Hospital and Institute of Pain Medicine, Central South University, Changsha, People’s Republic of China; 2Hunan Key Laboratory of Brain Homeostasis, Central South University, Changsha, People’s Republic of ChinaCorrespondence: Haocheng Zhou, Department of Pain, the Third Xiangya Hospital and Institute of Pain Medicine, Central South University, Changsha, People’s Republic of China, Email Haocheng.Zhou@csu.edu.cnPurpose: Post-mastectomy pain syndrome is a common yet debilitating neuropathic complication after breast cancer procedures, resulting in significantly reduced quality of life. Recently, emerging evidence has supported the therapeutic effect of magnesium administration in chronic pain. However, the role of magnesium supplementation in development of chronic pain after breast cancer surgery remains less known. The aim of this study was to evaluate therapeutic effect of magnesium supplementation on persistent pain after breast cancer procedure.Patients and Methods: This was a randomized, double-blind, placebo-controlled clinical trial. A total of 109 patients who underwent breast cancer procedure received magnesium-L-threonate (n = 48) or placebo (n = 61) for 12 weeks. Chronic pain incidence, short form of the McGill Pain Questionnaire (SF-MPQ), Generalized Anxiety Disorder Scale (GAD-7), Patient Health Questionnaire-9 (PHQ-9), Pittsburgh Sleep Quality Index (PSQI), and Telephone Interview for Cognitive Status (TICS) were evaluated at 3- and 6-month follow-up.Results: About 31% (15 out of 48) of patients reported chronic pain after magnesium supplementation, and 26% (16 out of 61) of the control group at 6-month follow-up respectively. Total scores of SF-MPQ were significantly increased in the control group 6 months after surgical intervention (mean difference, 1.475; 95% CI, − 2.730 to − 0.2211), but NOT in the magnesium treated group (mean difference, 1.250; 95% CI, − 2.775 to 0.2748). No significant differences were found between two cohorts on SF-MPQ, GAD-7, PHQ-9, PSQI, or TICS at each timepoint.Conclusion: Oral supplementation of magnesium-L-threonate did not effectively prevent the development of persistent pain in breast cancer survivors, nor provide sufficient pain relief over placebo. We did not observe improvement of pain, mood, sleep disorder, or cognitive function after 12-week magnesium supplementation. Future study may focus on magnesium combined with other effective anti-neuropathic pain treatment.Keywords: breast cancer surgery, chronic pain, magnesium-l-threonate, neuropathic pain, pain management |
| first_indexed | 2024-03-12T21:55:25Z |
| format | Article |
| id | doaj.art-be91fc76813640639715044382e65ca9 |
| institution | Directory Open Access Journal |
| issn | 1179-1314 |
| language | English |
| last_indexed | 2024-03-12T21:55:25Z |
| publishDate | 2023-07-01 |
| publisher | Dove Medical Press |
| record_format | Article |
| series | Breast Cancer: Targets and Therapy |
| spelling | doaj.art-be91fc76813640639715044382e65ca92023-07-25T19:04:50ZengDove Medical PressBreast Cancer: Targets and Therapy1179-13142023-07-01Volume 1549550485400A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Therapeutic Effect of Magnesium-L-Threonate Supplementation for Persistent Pain After Breast Cancer SurgeryNi YDeng FYu SZhang JZhang XHuang DZhou HYuncheng Ni,1 Fang Deng,1 Shanzi Yu,1 Jianping Zhang,1 Xiaoxue Zhang,1 Dong Huang,1,2 Haocheng Zhou1,2 1Department of Pain, the Third Xiangya Hospital and Institute of Pain Medicine, Central South University, Changsha, People’s Republic of China; 2Hunan Key Laboratory of Brain Homeostasis, Central South University, Changsha, People’s Republic of ChinaCorrespondence: Haocheng Zhou, Department of Pain, the Third Xiangya Hospital and Institute of Pain Medicine, Central South University, Changsha, People’s Republic of China, Email Haocheng.Zhou@csu.edu.cnPurpose: Post-mastectomy pain syndrome is a common yet debilitating neuropathic complication after breast cancer procedures, resulting in significantly reduced quality of life. Recently, emerging evidence has supported the therapeutic effect of magnesium administration in chronic pain. However, the role of magnesium supplementation in development of chronic pain after breast cancer surgery remains less known. The aim of this study was to evaluate therapeutic effect of magnesium supplementation on persistent pain after breast cancer procedure.Patients and Methods: This was a randomized, double-blind, placebo-controlled clinical trial. A total of 109 patients who underwent breast cancer procedure received magnesium-L-threonate (n = 48) or placebo (n = 61) for 12 weeks. Chronic pain incidence, short form of the McGill Pain Questionnaire (SF-MPQ), Generalized Anxiety Disorder Scale (GAD-7), Patient Health Questionnaire-9 (PHQ-9), Pittsburgh Sleep Quality Index (PSQI), and Telephone Interview for Cognitive Status (TICS) were evaluated at 3- and 6-month follow-up.Results: About 31% (15 out of 48) of patients reported chronic pain after magnesium supplementation, and 26% (16 out of 61) of the control group at 6-month follow-up respectively. Total scores of SF-MPQ were significantly increased in the control group 6 months after surgical intervention (mean difference, 1.475; 95% CI, − 2.730 to − 0.2211), but NOT in the magnesium treated group (mean difference, 1.250; 95% CI, − 2.775 to 0.2748). No significant differences were found between two cohorts on SF-MPQ, GAD-7, PHQ-9, PSQI, or TICS at each timepoint.Conclusion: Oral supplementation of magnesium-L-threonate did not effectively prevent the development of persistent pain in breast cancer survivors, nor provide sufficient pain relief over placebo. We did not observe improvement of pain, mood, sleep disorder, or cognitive function after 12-week magnesium supplementation. Future study may focus on magnesium combined with other effective anti-neuropathic pain treatment.Keywords: breast cancer surgery, chronic pain, magnesium-l-threonate, neuropathic pain, pain managementhttps://www.dovepress.com/a-randomized-double-blind-placebo-controlled-trial-to-evaluate-the-the-peer-reviewed-fulltext-article-BCTTbreast cancer surgerychronic painmagnesium-l-threonateneuropathic painpain management |
| spellingShingle | Ni Y Deng F Yu S Zhang J Zhang X Huang D Zhou H A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Therapeutic Effect of Magnesium-L-Threonate Supplementation for Persistent Pain After Breast Cancer Surgery Breast Cancer: Targets and Therapy breast cancer surgery chronic pain magnesium-l-threonate neuropathic pain pain management |
| title | A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Therapeutic Effect of Magnesium-L-Threonate Supplementation for Persistent Pain After Breast Cancer Surgery |
| title_full | A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Therapeutic Effect of Magnesium-L-Threonate Supplementation for Persistent Pain After Breast Cancer Surgery |
| title_fullStr | A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Therapeutic Effect of Magnesium-L-Threonate Supplementation for Persistent Pain After Breast Cancer Surgery |
| title_full_unstemmed | A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Therapeutic Effect of Magnesium-L-Threonate Supplementation for Persistent Pain After Breast Cancer Surgery |
| title_short | A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Therapeutic Effect of Magnesium-L-Threonate Supplementation for Persistent Pain After Breast Cancer Surgery |
| title_sort | randomized double blind placebo controlled trial to evaluate the therapeutic effect of magnesium l threonate supplementation for persistent pain after breast cancer surgery |
| topic | breast cancer surgery chronic pain magnesium-l-threonate neuropathic pain pain management |
| url | https://www.dovepress.com/a-randomized-double-blind-placebo-controlled-trial-to-evaluate-the-the-peer-reviewed-fulltext-article-BCTT |
| work_keys_str_mv | AT niy arandomizeddoubleblindplacebocontrolledtrialtoevaluatethetherapeuticeffectofmagnesiumlthreonatesupplementationforpersistentpainafterbreastcancersurgery AT dengf arandomizeddoubleblindplacebocontrolledtrialtoevaluatethetherapeuticeffectofmagnesiumlthreonatesupplementationforpersistentpainafterbreastcancersurgery AT yus arandomizeddoubleblindplacebocontrolledtrialtoevaluatethetherapeuticeffectofmagnesiumlthreonatesupplementationforpersistentpainafterbreastcancersurgery AT zhangj arandomizeddoubleblindplacebocontrolledtrialtoevaluatethetherapeuticeffectofmagnesiumlthreonatesupplementationforpersistentpainafterbreastcancersurgery AT zhangx arandomizeddoubleblindplacebocontrolledtrialtoevaluatethetherapeuticeffectofmagnesiumlthreonatesupplementationforpersistentpainafterbreastcancersurgery AT huangd arandomizeddoubleblindplacebocontrolledtrialtoevaluatethetherapeuticeffectofmagnesiumlthreonatesupplementationforpersistentpainafterbreastcancersurgery AT zhouh arandomizeddoubleblindplacebocontrolledtrialtoevaluatethetherapeuticeffectofmagnesiumlthreonatesupplementationforpersistentpainafterbreastcancersurgery AT niy randomizeddoubleblindplacebocontrolledtrialtoevaluatethetherapeuticeffectofmagnesiumlthreonatesupplementationforpersistentpainafterbreastcancersurgery AT dengf randomizeddoubleblindplacebocontrolledtrialtoevaluatethetherapeuticeffectofmagnesiumlthreonatesupplementationforpersistentpainafterbreastcancersurgery AT yus randomizeddoubleblindplacebocontrolledtrialtoevaluatethetherapeuticeffectofmagnesiumlthreonatesupplementationforpersistentpainafterbreastcancersurgery AT zhangj randomizeddoubleblindplacebocontrolledtrialtoevaluatethetherapeuticeffectofmagnesiumlthreonatesupplementationforpersistentpainafterbreastcancersurgery AT zhangx randomizeddoubleblindplacebocontrolledtrialtoevaluatethetherapeuticeffectofmagnesiumlthreonatesupplementationforpersistentpainafterbreastcancersurgery AT huangd randomizeddoubleblindplacebocontrolledtrialtoevaluatethetherapeuticeffectofmagnesiumlthreonatesupplementationforpersistentpainafterbreastcancersurgery AT zhouh randomizeddoubleblindplacebocontrolledtrialtoevaluatethetherapeuticeffectofmagnesiumlthreonatesupplementationforpersistentpainafterbreastcancersurgery |